Kristensen, I. B., Norseth, H., Loigom, D., Gregersen, H., Slørdahl, T. S., Pedersen, R., Haukås, E., Szatkowski, D., Hansen, D., Schjesvold, F., Lund, T. (2025). Selinexor with alternating bortezomib or lenalidomide plus dexamethasone in transplant ineligible newly diagnosed multiple myeloma patients (SABLe), report of primary endpoint, nordic myeloma study group 29/21. Blood. https://doi.org/10.1182/blood-2025-4034